- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: D.2, F.3, N.5, N.154
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 4 residues within 4Å:- Chain B: D.2, F.3, N.5, N.154
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 4 residues within 4Å:- Chain C: D.2, F.3, N.5, N.154
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 4 residues within 4Å:- Chain D: D.2, F.3, N.5, N.154
No protein-ligand interaction detected (PLIP)- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.3: 2 residues within 4Å:- Chain A: N.65, W.357
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain A- Water bridges: B:K.383
- Hydrogen bonds: A:N.65, A:W.357
NAG.8: 2 residues within 4Å:- Chain B: N.65, W.357
3 PLIP interactions:1 interactions with chain D, 2 interactions with chain B- Water bridges: D:K.383
- Hydrogen bonds: B:N.65, B:W.357
NAG.13: 2 residues within 4Å:- Chain C: N.65, W.357
3 PLIP interactions:2 interactions with chain C, 1 interactions with chain A- Hydrogen bonds: C:N.65, C:W.357
- Water bridges: A:K.383
NAG.18: 2 residues within 4Å:- Chain D: N.65, W.357
3 PLIP interactions:2 interactions with chain D, 1 interactions with chain C- Hydrogen bonds: D:N.65, D:W.357
- Water bridges: C:K.383
- 8 x CA: CALCIUM ION(Non-covalent)(Non-functional Binders)
CA.4: 5 residues within 4Å:- Chain A: D.213, N.214, G.217, D.244, N.266
6 PLIP interactions:4 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.213, A:G.217, A:D.244, A:N.266, H2O.1, H2O.4
CA.5: 3 residues within 4Å:- Ligands: CA.10, CA.15, CA.20
No protein-ligand interaction detected (PLIP)CA.9: 5 residues within 4Å:- Chain B: D.213, N.214, G.217, D.244, N.266
6 PLIP interactions:4 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.213, B:G.217, B:D.244, B:N.266, H2O.16, H2O.19
CA.10: 3 residues within 4Å:- Ligands: CA.5, CA.15, CA.20
No protein-ligand interaction detected (PLIP)CA.14: 5 residues within 4Å:- Chain C: D.213, N.214, G.217, D.244, N.266
6 PLIP interactions:4 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:D.213, C:G.217, C:D.244, C:N.266, H2O.31, H2O.35
CA.15: 3 residues within 4Å:- Ligands: CA.5, CA.10, CA.20
No protein-ligand interaction detected (PLIP)CA.19: 5 residues within 4Å:- Chain D: D.213, N.214, G.217, D.244, N.266
6 PLIP interactions:4 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:D.213, D:G.217, D:D.244, D:N.266, H2O.47, H2O.50
CA.20: 3 residues within 4Å:- Ligands: CA.5, CA.10, CA.15
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Varghese, J.N. et al., Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure (1998)
- Release Date
- 1998-11-11
- Peptides
- NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x CA: CALCIUM ION(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Varghese, J.N. et al., Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure (1998)
- Release Date
- 1998-11-11
- Peptides
- NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A